This site requires JavaScript to be enabled to work properly. Please modify your settings or use a different browser to continue

      

Leaving GSK Pro

You are leaving GSK Pro to visit a separate website not associated with GSK Pro, a portal for US Healthcare Professionals.There are website links to third-party sites on GSK Pro. GSK is not responsible for content on third-party websites.

Continue

Cancel

SHINGRIX: Availability and Ordering Update

Today, SHINGRIX is available and GSK can meet demand across all distribution channels. From the launch of SHINGRIX in 2017 through March 2020, demand for shingles immunization has been very strong. Over that time, we estimate approximately 17 million people in the US received at least one dose of SHINGRIX.1

However, national stay-at-home measures, prompted by the COVID-19 pandemic, have resulted in a significant decrease in patients seeking routine healthcare, including immunizations. This reduction in demand for vaccination has resulted in improved inventory of SHINGRIX.

In order to support and encourage a return to the robust pace and progress of immunization before the pandemic and timely second-dose completion, we have taken the following steps:

  • Removed ordering caps
  • Introduced direct-to-patient education via mass media (eg, television and digital)
You are encouraged to order through your preferred channel to help meet your needs for SHINGRIX. This includes ordering through your preferred wholesaler or via easy, online ordering at GSKDirect.

You may also be interested in:

Learn how to store SHINGRIX and about the importance of proper dosing. Be sure to schedule a second dose for your patients, anytime between 2 and 6 months after the first dose.2

Watch a range of informative videos, including highlights of pivotal trials, and MOA and reconstitution videos.

Our library of resources includes handouts for patients, plus pocket and reference guides for you and your staff.

 

References: 1. Data on file; GSK. 2. Prescribing Information for SHINGRIX.  

Trademarks are property of their respective owners.